Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3406 EUR | -0.58% |
|
-.--% | -45.94% |
Business Summary
Number of employees: 37
Managers
Managers | Title | Age | Since |
---|---|---|---|
Todd Branning
CEO | Chief Executive Officer | 54 | 09/01/22 |
Dani Stoltzfus
PRN | Corporate Officer/Principal | - | - |
Ron Sarkar
PRN | Corporate Officer/Principal | - | 31/10/21 |
Alan Scrivner
LAW | General Counsel | - | 31/08/21 |
Shannon McCarthy
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dov Goldstein
CHM | Chairman | 56 | 11/07/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,751,590 | 3,249,699 ( 86.62 %) | 0 | 86.62 % |
Company contact information
NeuBase Therapeutics, Inc.
350 Technology Drive Suite 421
15219, Pittsburgh
+
http://www.neubasetherapeutics.com![address NeuBase Therapeutics, Inc.(O7P)](https://cdn.zonebourse.com/static/address/62120068.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-45.94% | 1.39M | |
+38.65% | 39.1B | |
-8.62% | 38.76B | |
+26.95% | 31.24B | |
+10.74% | 25.9B | |
-13.50% | 25.8B | |
+44.87% | 14.06B | |
+34.36% | 13.12B | |
-7.14% | 11.32B | |
-12.61% | 10.68B |
- Stock Market
- Equities
- O7P Stock
- Company NeuBase Therapeutics, Inc.